Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cellsShingo Kozono, Xiao Zhen Zhou, Hyuk‐Soo Seo et al.|Nature Communications|2018Cited by 161
Bone marrow stromal cells protect acute myeloid leukemia cells from anti‐CD44 therapy partly through regulating PI3K/Akt–p27<sup>Kip1</sup> axisPing Chen, Yuanzhong Chen|Molecular Carcinogenesis|2014Cited by 53
TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signalingXiaofang Chen, Yuanzhong Chen|Cell Death and Disease|2021Cited by 34
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathwaysXiaolan Lian, Yuanzhong Chen|Journal of Hematology & Oncology|2018Cited by 33